A novel H-FABP assay and a fast prognostic score for risk assessment of normotensive pulmonary embolism

Thrombosis and Haemostasis

Volumn 111, Issue 5, 2014, Pages 996-1003

  Dellas, Claudia ^a   Tschepe, Merle ^a   Seeber, Valerie ^b   Zwiener, Isabella ^b   Kuhnert, Katherina ^a   Schäfer, Katrin ^a,b   Hasenfuß, Gerd ^a   Konstantinides, Stavros ^b   Lankeit, Mareike ^a,b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FATTY ACID BINDING PROTEIN; HEART TYPE FATTY ACID BINDING PROTEIN; UNCLASSIFIED DRUG; FABP3 PROTEIN, HUMAN;

ADULT; ADVERSE OUTCOME; AGED; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL VENTILATION; DEATH; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAINTNESS; FEMALE; FOLLOW UP; HEART RIGHT VENTRICLE FUNCTION; HUMAN; IMMUNOASSAY; IMMUNOTURBIDIMETRY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RECANALIZATION; RECEIVER OPERATING CHARACTERISTIC; RESUSCITATION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SIMPLIFIED PULMONARY EMBOLISM SEVERITY INDEX; TACHYCARDIA; TRANSTHORACIC ECHOCARDIOGRAPHY; BLOOD PRESSURE; COMPARATIVE STUDY; COMPLICATION; DISEASE COURSE; EVALUATION STUDY; HEART ARREST; LABORATORY AUTOMATION; METABOLISM; MORTALITY; PHOTOMETRY; PROCEDURES; PROSPECTIVE STUDY; PULMONARY EMBOLISM; REPRODUCIBILITY; RESPIRATORY INSUFFICIENCY; RISK; SEVERITY OF ILLNESS INDEX; SURVIVAL;

AGED; AUTOMATION, LABORATORY; BLOOD PRESSURE; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACID-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; HEART ARREST; HUMANS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; REPRODUCIBILITY OF RESULTS; RESPIRATORY INSUFFICIENCY; RISK; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 84899747631     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-08-0663     Document Type: Article

References (31)

1. Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet 2012; 379: 1835-1846.
2. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353: 1386-1389.
3. Laporte S, Mismetti P, Decousus H, et al. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation 2008; 117: 1711-1716.
4. Pollack CV, Schreiber D, Goldhaber SZ, et al. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J Am Coll Cardiol 2011; 57: 700-706.
5. Ng AC, Chung T, Yong AS, et al. Long-term cardiovascular and noncardiovascular mortality of 1023 patients with confirmed acute pulmonary embolism. Circ Cardiovasc Qual Outcomes 2011; 4: 122-128.
6. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29: 2276-2315.
7. Apostolakis S, Konstantinides S. The Right Ventricle in Health and Disease: Insights into Physiology, Pathophysiology and Diagnostic Management. Cardiology 2012; 121: 263-273.
8. Sanchez O, Trinquart L, Colombet I, et al. Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. Eur Heart J 2008; 29: 1569-1577.
9. Becattini C, Agnelli G, Vedovati MC, et al. Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test. Eur Heart J 2011; 32: 1657-1663.
10. Klok FA, Mos IC, Huisman MV. Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis. Am J Respir Crit Care Med 2008; 178: 425-430.
11. Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation 2007; 116: 427-433.
12. Jimenez D, Aujesky D, Moores L, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010; 170: 1383-1389.
13. Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005; 172: 1041-1046.
14. Puls M, Dellas C, Lankeit M, et al. Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism. Eur Heart J 2007; 28: 224-229.
15. Kaczynska A, Pelsers MM, Bochowicz A, et al. Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism. Clin Chim Acta 2006; 371: 117-123.
16. Dellas C, Puls M, Lankeit M, et al. Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism. J Am Coll Cardiol 2010; 55: 2150-2157.
17. Boscheri A, Wunderlich C, Langer M, et al. Correlation of heart-type fatty acidbinding protein with mortality and echocardiographic data in patients with pulmonary embolism at intermediate risk. Am Heart J 2010; 160: 294-300.
18. Lankeit M, Friesen D, Schafer K, et al. A simple score for rapid risk assessment of non-high-risk pulmonary embolism. Clin Res Cardiol 2013; 102: 73-80.
19. Lankeit M, Jimenez D, Kostrubiec M, et al. Predictive value of the high-sensitivity troponin T assay and the simplified Pulmonary Embolism Severity Index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study. Circulation 2011; 124: 2716-2724.
20. Lankeit M, Friesen D, Aschoff J, et al. Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism. Eur Heart J 2010; 31: 1836-1844.
21. National Kidney Foundation. K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39: S1-S000.
22. Pencina MJ, D'Agostino RB, Sr., D'Agostino RB, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172.
23. The PEITHO Steering Committee. Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial. Am Heart J 2012; 163: 33-38.
24. Coutance G, Cauderlier E, Ehtisham J, et al. The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a meta-analysis. Crit Care 2011; 15: R103.
25. Kostrubiec M, Pruszczyk P, Bochowicz A, et al. Biomarker-based risk assessment model in acute pulmonary embolism. Eur Heart J 2005; 26: 2166-2172.
26. Jimenez D, Uresandi F, Otero R, et al. Troponin-based risk stratification of patients with acute nonmassive pulmonary embolism: systematic review and metaanalysis. Chest 2009; 136: 974-982.
27. Carless DR, Wnek M, Knox C, et al. Clinical and analytical evaluation of an immunoturbidimetric heart-type fatty acid-binding protein assay. Scand J Clin Lab Invest 2013; 73: 48-53.
28. Viswanathan K, Kilcullen N, Morrell C, et al. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative. J Am Coll Cardiol 2010; 55: 2590-2598.
29. McMahon CG, Lamont JV, Curtin E, et al. Diagnostic accuracy of heart-type fatty acid-binding protein for the early diagnosis of acute myocardial infarction. Am J Emerg Med 2012; 30: 267-274.
30. Lankeit M, Konstantinides S. Is it time for home treatment of pulmonary embolism? Eur Respir J 2012; 40: 742-749.
31. Aujesky D, Roy PM, Verschuren F, et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 2011; 378: 41-48.